Abstract

Fast and efficient homing and engraftment of hematopoietic stem progenitor cells (HSPCs) is crucial for positive clinical outcomes from transplantation. We found that this process depends on activation of the Nlrp3 inflammasome, both in the HSPCs to be transplanted and in the cells in the recipient bone marrow (BM) microenvironment. For the first time we provide evidence that functional deficiency in the Nlrp3 inflammasome in transplanted cells or in the host microenvironment leads to defective homing and engraftment. At the molecular level, functional deficiency of the Nlrp3 inflammasome in HSPCs leads to their defective migration in response to the major BM homing chemoattractant stromal-derived factor 1 (SDF-1) and to other supportive chemoattractants, including sphingosine-1-phosphate (S1P) and extracellular adenosine triphosphate (eATP). We report that activation of the Nlrp3 inflammasome increases autocrine release of eATP, which promotes incorporation of the CXCR4 receptor into membrane lipid rafts at the leading surface of migrating cells. On the other hand, a lack of Nlrp3 inflammasome expression in BM conditioned for transplantation leads to a decrease in expression of SDF-1 and danger-associated molecular pattern molecules (DAMPs), which are responsible for activation of the complement cascade (ComC), which in turn facilitates the homing and engraftment of HSPCs.

Highlights

  • Hematopoietic transplantation is based on intravenous infusion of hematopoietic stem progenitor cells (HSPCs), which, in response to bone marrow (BM)-expressed chemoattractants, migrate and home to BM hematopoietic niches [1,2,3]

  • As we demonstrated in the past, for optimal sensing of stromal-derived factor 1 (SDF-1) gradients and intracellular signaling in migrating HSPCs, CXCR4 has to be incorporated into cell membrane lipid rafts [10, 11]

  • Proper Expression of the Nlrp3 Inflammasome in HSPCs Is Required for their Migration toward BMHoming Chemoattractants

Read more

Summary

Introduction

Hematopoietic transplantation is based on intravenous infusion of hematopoietic stem progenitor cells (HSPCs), which, in response to bone marrow (BM)-expressed chemoattractants, migrate and home to BM hematopoietic niches [1,2,3] This process is followed by their engraftment and expansion to repopulate recipient myeloablated BM. Blockade of the Nlrp inflammasome by the small-molecule inhibitor MCC950 led to a decrease in the release of HSPCs from BM into PB [12], and this result was subsequently reproduced in Nlrp3-KO mice In this current investigation we became interested in the role of the Nlrp inflammasome complex in the reverse process, which is homing and engraftment of transplanted HSPCs

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call